Page last updated: 2024-11-05

thioridazine and Carcinoma, Epidermoid

thioridazine has been researched along with Carcinoma, Epidermoid in 4 studies

Thioridazine: A phenothiazine antipsychotic used in the management of PHYCOSES, including SCHIZOPHRENIA.
thioridazine : A phenothiazine derivative having a methylsulfanyl subsitituent at the 2-position and a (1-methylpiperidin-2-yl)ethyl] group at the N-10 position.

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19901 (25.00)18.7374
1990's0 (0.00)18.2507
2000's1 (25.00)29.6817
2010's2 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Choi, AR1
Kim, JH1
Yoon, S1
Li, H1
Juan, L1
Xia, L1
Wang, Y1
Bao, Y1
Sun, G1
Sundberg, AL1
Steffen, AC1
Hercbergs, A1

Other Studies

4 other studies available for thioridazine and Carcinoma, Epidermoid

ArticleYear
Thioridazine specifically sensitizes drug-resistant cancer cells through highly increase in apoptosis and P-gp inhibition.
    Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine, 2014, Volume: 35, Issue:10

    Topics: Antineoplastic Agents; Apoptosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blotting,

2014
Thioridazine Sensitizes Esophageal Carcinoma Cell Lines to Radiotherapy-Induced Apoptosis In Vitro and In Vivo.
    Medical science monitor : international medical journal of experimental and clinical research, 2016, Jul-25, Volume: 22

    Topics: Animals; Apoptosis; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Proliferation; Esophageal Neopl

2016
Enhancing the effect of radionuclide tumor targeting, using lysosomotropic weak bases.
    International journal of radiation oncology, biology, physics, 2007, Jan-01, Volume: 67, Issue:1

    Topics: Amantadine; Ammonium Chloride; Antimalarials; Antipsychotic Agents; Antiviral Agents; Astatine; Carc

2007
Thioridazine: a radiation enhancer in advanced cervical cancer?
    Lancet (London, England), 1988, Sep-24, Volume: 2, Issue:8613

    Topics: Carcinoma, Squamous Cell; Combined Modality Therapy; Female; Humans; Middle Aged; Pelvic Neoplasms;

1988